MDT

99.69

-0.44%↓

145.75

-0.67%↓

VEEV

239.89

+1.29%↑

HQY

97.32

+1.57%↑

PHR.US

17.54

+2.57%↑

MDT

99.69

-0.44%↓

145.75

-0.67%↓

VEEV

239.89

+1.29%↑

HQY

97.32

+1.57%↑

PHR.US

17.54

+2.57%↑

MDT

99.69

-0.44%↓

145.75

-0.67%↓

VEEV

239.89

+1.29%↑

HQY

97.32

+1.57%↑

PHR.US

17.54

+2.57%↑

MDT

99.69

-0.44%↓

145.75

-0.67%↓

VEEV

239.89

+1.29%↑

HQY

97.32

+1.57%↑

PHR.US

17.54

+2.57%↑

MDT

99.69

-0.44%↓

145.75

-0.67%↓

VEEV

239.89

+1.29%↑

HQY

97.32

+1.57%↑

PHR.US

17.54

+2.57%↑

Kodu・Aktsiate loetelu・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Avatud

SektorTervishoid

37.51 2.49

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

36.52

Max

Põhinäitajad
By Trading Economics
Sissetulek	11M 51M
Müük	39M 239M
P/E Sektori keskmine	11.593 88.032
Aktsiakasum	1.08
Kasumimarginaal	21.242
Töötajad	268
EBITDA	14M 73M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+18.64% upside

Turustatistika
By TradingEconomics
Turukapital	429M 2.1B
Eelmine avamishind	35.02
Eelmine sulgemishind	37.51

Uudiste sentiment

By Acuity

50%

164 / 373 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

29.8 / N/A Toetus ja vastupanu

Harmony Biosciences Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. jaan 2026, 21:14 UTC

Suurimad hinnamuutused turgudel

Ventyx Biosciences Gains on Report of Possible $1 Billion Eli Lilly Deal

6. jaan 2026, 19:23 UTC

Omandamised, ülevõtmised, äriostud

OneStream to Go Private Through $6.4 Billion Hg Acquisition

6. jaan 2026, 17:41 UTC

Suurimad hinnamuutused turgudel

Blink Charging Shares Rise as EV Chargers Begin Accepting Cryptocurrency

6. jaan 2026, 15:46 UTC

Omandamised, ülevõtmised, äriostud

Advent International Leads InPost Takeover Offer, Sky News Says

6. jaan 2026, 15:37 UTC

Suurimad hinnamuutused turgudel

Terrestrial Energy Shares Rise After DOE Agreement For Nuclear Plant Development

6. jaan 2026, 23:46 UTC

Market Talk

Nikkei May Decline After Hitting Record High -- Market Talk

6. jaan 2026, 23:35 UTC

Market Talk

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

6. jaan 2026, 23:19 UTC

Market Talk

Greatland 2Q Gold Output Strong, Sales Soft -- Market Talk

6. jaan 2026, 22:53 UTC

Market Talk

WiseTech, REA and CAR Look Best Insulated From AI Threat -- Market Talk

6. jaan 2026, 22:03 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6. jaan 2026, 22:03 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6. jaan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. jaan 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. jaan 2026, 21:12 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

6. jaan 2026, 21:12 UTC

Market Talk

Commodity Demand Helps Canada Reduce Reliance on Trade With U.S. -- Market Talk

6. jaan 2026, 20:59 UTC

Suurimad hinnamuutused turgudel

Omandamised, ülevõtmised, äriostud

Ventyx Biosciences Gains on Report of Possible $1B Eli Lilly Deal

6. jaan 2026, 20:40 UTC

Omandamised, ülevõtmised, äriostud

Acquisition of Ventyx Would Bring Lilly Into Emerging Category of Pills for Inflammation-Related Conditions -- WSJ

6. jaan 2026, 20:40 UTC

Omandamised, ülevõtmised, äriostud

Eli Lilly Nears Deal for Biotech Ventyx -- WSJ

6. jaan 2026, 20:40 UTC

Omandamised, ülevõtmised, äriostud

Deal Could Be Announced Imminently, Sources Say -- WSJ

6. jaan 2026, 20:40 UTC

Omandamised, ülevõtmised, äriostud

Eli Lilly in Advanced Talks to Buy Ventyx Biosciences For Over $1B, Sources Say -- WSJ

6. jaan 2026, 20:01 UTC

Market Talk

Oil Futures Give Back Post-Venezuela Incursion Gains -- Market Talk

6. jaan 2026, 19:52 UTC

Market Talk

U.S. Natural Gas Falls Awaiting Colder Weather -- Market Talk

6. jaan 2026, 19:46 UTC

Omandamised, ülevõtmised, äriostud

Under Armour Stock Rises After the 'Warren Buffet of Canada' Boosts Its Stake -- Barrons.com

6. jaan 2026, 19:08 UTC

Omandamised, ülevõtmised, äriostud

OneStream to Go Private Through $6.4B Hg Acquisition

6. jaan 2026, 18:28 UTC

Omandamised, ülevõtmised, äriostud

These Stocks Are Moving the Most Today: Sandisk, Nvidia, AMD, Palantir, OneStream, SoFi, Microchip, and More -- Barrons.com

6. jaan 2026, 17:20 UTC

Market Talk

Tulu

Financial Services Roundup: Market Talk

6. jaan 2026, 17:20 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Health Care Roundup: Market Talk

6. jaan 2026, 15:57 UTC

Market Talk

Crude Futures Ease Back From Early Gains -- Market Talk

6. jaan 2026, 15:34 UTC

Market Talk

Tulu

Bank of Montreal Expects to Exit 2027 With ROE Hitting 15% Target -- Market Talk

6. jaan 2026, 15:27 UTC

Market Talk

German Inflation Won't Fall Much Further in 2026 -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Harmony Biosciences Holdings Inc Prognoos

Hinnasiht

By TipRanks

18.64% tõus

12 kuu keskmine prognoos

Keskmine 43.6 USD 18.64%

Kõrge 55 USD

Madal 32 USD

Põhineb 6 Wall Streeti analüütiku instrumendi Harmony Biosciences Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

6 ratings

Osta

Hoia

Müü

Põhineb 6 analüütiku instrumendi Harmony Biosciences Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

29.8 / N/AToetus ja vastupanu

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

164 / 373 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.